沃森生物(300142.SZ)：公司在微生态健康和功能性营养干预领域的相关业务目前已进入实施阶段

Core Viewpoint - Watson Bio (300142.SZ) has entered the implementation phase for its business in the fields of microecological health and functional nutritional interventions, leveraging its existing R&D and industrialization capabilities to focus resources on project execution [1] Summary by Relevant Categories Business Development - The company is concentrating resources to advance the implementation of its projects in microecological health and functional nutrition [1] Clinical Trials and Regulatory Approval - The application of these projects for disease populations will require further clinical trials and regulatory submissions, with progress and outcomes subject to approval from relevant national authorities, indicating a level of uncertainty [1]